Management of ALS is suboptimal. Consequently, quality improvement interventions are needed to improve ALS care. An evidence-based insight into how patients should be managed is essential when developing quality improvement interventions. Therefore, this study aimed to map, categorize and summarize international guidance on the management and care of ALS and to identify gaps in this guidance by means of a mapping review. Literature was searched for clinical practice guidelines, quality indicators and evidence-based clinical summaries. A content analysis and meta-synthesis of the included literature was performed. Interventions and outcomes used in the management and care of ALS were identified and categorized. Furthermore, the amount of gui...
Despite being one of the most devastating diseases known, there is little evidence for diagnosing an...
BACKGROUND: Amyotrophic lateral sclerosis (ALS or Lou Gehrigs disease) is a neurodegenerative diseas...
Introduction: Universally established comprehensive clinical bulbar scales objectively assessing dis...
Management of ALS is suboptimal. Consequently, quality improvement interventions are needed to impro...
Management of ALS is suboptimal. Consequently, quality improvement interventions are needed to impro...
International audienceObjective: To evaluate the degree of application of the recommendations edited...
American Academy of Neurology (AAN) is charged with developing practice parameters for physicians. T...
The care of a patient with amyotrophic lateral sclerosis is complex and involved a wide multidiscipl...
Mission statement. The Quality Standards Subcommittee (QSS) of the American Academy of Neurology (AA...
Background and purpose: Our objective was to evaluate the extent to which the 2005 recommendations o...
The evidence base for diagnosis and management of ALS is still weak, and curative therapy is lacking...
Standard recommendations for the clinical management of patient with ALS have been edited in recent ...
Mission statement. The Quality Standards Subcommittee (QSS) of the American Academy of Neurology (AA...
Introduction: Amyotrophic lateral sclerosis (ALS) is a progressive motor neuron disease that affects...
Despite being one of the most devastating diseases known, there is little evidence for diagnosing an...
BACKGROUND: Amyotrophic lateral sclerosis (ALS or Lou Gehrigs disease) is a neurodegenerative diseas...
Introduction: Universally established comprehensive clinical bulbar scales objectively assessing dis...
Management of ALS is suboptimal. Consequently, quality improvement interventions are needed to impro...
Management of ALS is suboptimal. Consequently, quality improvement interventions are needed to impro...
International audienceObjective: To evaluate the degree of application of the recommendations edited...
American Academy of Neurology (AAN) is charged with developing practice parameters for physicians. T...
The care of a patient with amyotrophic lateral sclerosis is complex and involved a wide multidiscipl...
Mission statement. The Quality Standards Subcommittee (QSS) of the American Academy of Neurology (AA...
Background and purpose: Our objective was to evaluate the extent to which the 2005 recommendations o...
The evidence base for diagnosis and management of ALS is still weak, and curative therapy is lacking...
Standard recommendations for the clinical management of patient with ALS have been edited in recent ...
Mission statement. The Quality Standards Subcommittee (QSS) of the American Academy of Neurology (AA...
Introduction: Amyotrophic lateral sclerosis (ALS) is a progressive motor neuron disease that affects...
Despite being one of the most devastating diseases known, there is little evidence for diagnosing an...
BACKGROUND: Amyotrophic lateral sclerosis (ALS or Lou Gehrigs disease) is a neurodegenerative diseas...
Introduction: Universally established comprehensive clinical bulbar scales objectively assessing dis...